期刊文献+

儿童脂蛋白肾病1例报告并文献复习 被引量:2

One case report of lipoprotein glomerulopathy with literature review
下载PDF
导出
摘要 目的探讨儿童脂蛋白肾病(LPG)的临床及预后。方法回顾性分析1例儿童LPG的临床资料,归纳总结国内外报道的儿童LPG的临床特点及预后。结果患儿,女,9岁,以尿频起病,初次尿检提示菌尿、血尿、蛋白尿,规律抗感染治疗1周后,仍有血尿、蛋白尿,血清白蛋白轻度降低,高脂血症,轻度贫血;肾脏组织活检,镜下可见肥大肾小球,扩张的肾小球毛细血管管腔,其内充以脂蛋白栓子,油红O染色阳性;电镜下多见层状或簇状"栓子"内含颗粒状脂质空泡。基因检测APOE Tokyo(Leu141-Lys143→0)。诊断为LPG,给予降脂治疗后病情明显缓解。结论儿童LPG罕见,血脂水平显著增高,激素治疗无效,肾脏穿刺活检是确诊的主要依据,基因检测提示其遗传背景;降脂治疗可缓解病情进展。 Objective To discuss the clinical characteristics and prognosis of lipoprotein glomerulopathy(LPG) in children.Method Clinical data of one pediatric LPG patient were retrospectively analyzed.The clinical features and prognosis of childhood LPG were summarized based on literature review.Results A nine years old girl presented with frequent urination.The first urine test revealed hematuria and proteinuria.After one week anti-infection treatment,the hematuria and proteinuria were continued.The serum albumin was slightly reduced.The hyperlipidemia and mild anemia were emerged.Kidney biopsy showed that enlarged glomeruli,with dilated capillary loops and weak eosinophilic lipoprotein thrombi in the capillary lumina under the light microscope; layered or tufted "embolus" containing particulated lipid vacuoles under electron microscope.Gene sequencing identified APOE Tokyo(Leu141-Lys143→0).The diagnosis of LPG was confirmed.The lipid-lowering therapy was administrated and the disease was alleviated.Conclusion LPG is a rare disease in children.The level of blood lipid was significantly increased,and the hormone therapy was ineffective.Kidney biopsy is the main basis for diagnosis.The genetic testing can prompt the genetic background.Lipid lowering therapy can relieve the progress of the disease.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第2期120-123,共4页 Journal of Clinical Pediatrics
关键词 脂蛋白肾病 APOE基因 儿童 lipoprotein glomerulopathy APOE gene child
  • 相关文献

参考文献26

  • 1Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopa- thy.. glomerular lipoprotein thrombi in a patient with hyper-lipoproteinemia [J]. Am J Kidney Dis, 1989, 13(2).. 148-153.
  • 2Saito T, MatsunagaA, Ito K, et al. Topics in lipoprotein glomerulopathy, an overview [J]. Clin Exp Nephrol, 2014, 18(2): 214-217.
  • 3Konishi K, Saruta T, Kuramochi S, et al. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy [J]. Neph- ron, 1999, 83(3): 214-218.
  • 4Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E sendal (Arginine 145--,Proline): A New Variant Associate with Lipoprotein Glomerulopathy [J]. J Am Soc Nephrol, 1997, 8(5): 820-823.
  • 5Mitani A, Ishigami M, Watase K, et al. A Novel Apoli- poprotein E Mutation, APOE Osaka (Arg158 Pro), in a Dyslipidemie Patient with Lipoprotein Glomerulopathy [J]. J Atheroscler Thromb, 2011, 18(6): 531-535.
  • 6Luo B, Huang F, Liu Q, et al. Identification of apo- lipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy [J]. Am J Nephrol, 2008, 28(2): 347-353.
  • 7Kinomura M, Sugiyama H, Saito T, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glo- merulopathy [J]. Nephrol Dial Transplant, 2008, 23(2): 751-756.
  • 8Matsunaga A, Sasaki J, Komatsu T, et al. A novel apo- lipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy [J]. Kidney Int, 1999, 56(2): 421-427.
  • 9Ogawa T, Maruyama K, Hattori H, et al. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomer- ulopathy [J]. Pediatr Nephrol, 2000, 14(2): 149-151.
  • 10Liao MT, Tsai I J, Cheng HT, et al. A rare cause of child- hood-onset nephrotic syndrome: lipoprotein glomerulopa- thy[J].ClinNephrol, 2012, 78(3): 237-240.

二级参考文献47

  • 1陈燕,王庆文.全血脂蛋白吸附治疗脂蛋白肾病[J].肾脏病与透析肾移植杂志,2004,13(5):493-498. 被引量:13
  • 2陈惠萍,黎磊石.脂蛋白肾小球病[J].肾脏病与透析肾移植杂志,1997,6(2):182-184. 被引量:20
  • 3Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis,2006,47(2) : 199 - 211.
  • 4Zhang B, Liu ZH, Zeng CH, et al. Clinicopathological and genetic characteristics in (Thinese patients with lipoprotein glomerulopathy.J Nephrol,2008,21(1):110-117.
  • 5Jennette J,Olson J, Schwartz M, et al. Hepinstall' s Pat hology of the Kidney, 6th edition. Lippincott Williams & Wilkins, 2007. 1203- 1205.
  • 6[8]Wen M, Segerer S, Dantas M,et al. Renal injury in Apolipoprotein E-Deficient mice. Lab Invest, 2002 ,82:999
  • 7[12]Li LS, Liu ZH, Ji DX,et al. Novel effective treatment of lipoprotein glomerulopathy-immunoadsorption onto protein A. J Am Soc Nephrol, 2001,12:A0592
  • 8[13]Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis, 2003,41:244
  • 9[14]Arai T, Yamashita S, Yamane M,et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis, 2003,169: 293
  • 10[15]Nakaji S. Current Topics on immunoadsorption therapy. Therapeutic apheresis,2001,5:301

共引文献33

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部